To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma. Academic Article uri icon

Overview

authors

  • Martin, Peter
  • Goy, Andre
  • Ramchandren, Radhakrishnan
  • Ferrante, Lucille
  • Londhe, Anil
  • McGowan, Tracy
  • Bartlett, Nancy L

publication date

  • February 20, 2019

Identity

Scopus Document Identifier

  • 85062027279

Digital Object Identifier (DOI)

  • 10.1177/1078155219831435

PubMed ID

  • 30786822

Additional Document Info

volume

  • 25

issue

  • 4